Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0338 Transporter Info | ||||
Gene Name | SLC39A10 | ||||
Transporter Name | Zinc transporter ZIP10 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ATF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FOS |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Protein c-Fos | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Cervix; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein c-Fos (FOS) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FOSL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Fos-related antigen 2 | Transcription Factor Info | ||||
Tissue |
Brain; Breast; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 2 (FOSL2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in K562 cells | [5] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC39A10 gene in K562 cells, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Cervix; Colon; Coronary artery; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC39A10 gene in medulloblastoma condition | [6] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC39A10 gene in medulloblastoma condition, which leads to a decreased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in colorectal cancer condition | [7] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC39A10 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Brain; Colon; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Blood; Cervix; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Cervix | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to activate the transcription of SLC39A10 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon2 |
Binding to SLC39A10 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC39A10 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Estrogen receptor (ESR1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in ER(-) breast cancer condition | [10] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC39A10 gene in ER(-) breast cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
PGR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Progesterone receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Progesterone receptor (PGR) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
VDR |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in THP-1 human monocytic leukemia cells condition | [11] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
1,25-dihydroxyvitamin D3 | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to activate the transcription of SLC39A10 gene in THP-1 human monocytic leukemia cells condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon2 |
Binding to SLC39A10 gene in health condition | [12] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC39A10 gene in health condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon3 |
Binding to SLC39A10 gene in THP-1 human monocytic leukemia cells condition | [13] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC39A10 gene in THP-1 human monocytic leukemia cells condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in hematopoiesis condition | [14] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of SLC39A10 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
GATA3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in breast cancer condition | [15] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLC39A10 gene in breast cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Heart | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
BCL11A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
B-cell lymphoma/leukemia 11A | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
B-cell lymphoma/leukemia 11A (BCL11A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
BCL6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
B-cell lymphoma 6 protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Tonsil | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
B-cell lymphoma 6 protein (BCL6) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
MECOM |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Histone-lysine N-methyltransferase MECOM | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Histone-lysine N-methyltransferase MECOM (MECOM) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
MTF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC39A10 gene in health condition | [16] | ||||
TF Protein Name |
Metal regulatory transcription factor 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Zinc | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Mtf1 KO mice | |||||
Detailed Description |
Metal regulatory transcription factor 1 (MTF1) has been reported to repress the transcription of SLC39A10 gene in health condition, which leads to a decreased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
HOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Homeobox protein Hox-A1 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Homeobox protein Hox-A1 (HOXA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
NKX2-1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Homeobox protein Nkx-2.1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Homeobox protein Nkx-2.1 (NKX2-1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Brain; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FOXA1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in prostate carcinoma condition | [17] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC39A10 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon2 |
Binding to SLC39A10 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC39A10 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
ELK3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in hypoxia condition | [18] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) has been reported to bind to the transcription of SLC39A10 gene in hypoxia condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFYA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit alpha | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit alpha (NFYA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MEF2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Myocyte-specific enhancer factor 2A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myocyte-specific enhancer factor 2A (MEF2A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in fibrosarcoma condition | [19] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC39A10 gene in fibrosarcoma condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in glioblastoma multiforme condition | [20] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC39A10 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
STAT5A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Signal transducer and activator of transcription 5A | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Signal transducer and activator of transcription 5A (STAT5A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
STAT5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Signal transducer and activator of transcription 5B | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Signal transducer and activator of transcription 5B (STAT5B) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in epithelial to mesenchymal transition condition | [21] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC39A10 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Transcriptional Phenomenon2 |
Binding to SLC39A10 gene in health condition | [22] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC39A10 gene in health condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
TP73 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Tumor protein p73 | Transcription Factor Info | ||||
Tissue |
Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Tumor protein p73 (TP73) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC39A10 gene in prostate cancer condition | [23] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC39A10 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
RUNX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [4] | ||||
TF Protein Name |
Runt-related transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 3 (RUNX3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [2] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
SMAD3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [1] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 3 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Mothers against decapentaplegic homolog 3 (SMAD3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC39A10 gene in epithelial ovarian cancer condition | [24] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC39A10 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10. | |||||
Class10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SETDB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC39A10 gene | [3] | ||||
TF Protein Name |
Histone-lysine N-methyltransferase SETDB1 | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Histone-lysine N-methyltransferase SETDB1 (SETDB1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.